Current treatment of nontuberculous mycobacteriosis: an update

Author： Esteban Jaime García-Pedrazuela María Muñoz-Egea María Carmen Alcaide Fernando

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.13, Iss.7, 2012-05, pp. : 967-986

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current treatment of atypical mycobacteriosis

By Esteban Jaime Ortiz-Pérez Alberto

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 17, 2009-12 ,pp. : 2787-2799

Informa Healthcare

Access to resources Recommend Favorite

Ethambutol/prednisolone/rifampicin: Disseminated nontuberculous mycobacteriosis and fever in an elderly patient: case report

Reactions Weekly, Vol. 1, Iss. 1240, 2009-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Current Status of CETP Inhibitors in the Treatment of Hyperlipidemia: An Update

Current Clinical Pharmacology, Vol. 7, Iss. 2, 2012-01 ,pp. : 102-110

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Pharmacology of Current and Future Drugs for the Acute Treatment of Migraine: A Review and An Update

Current Clinical Pharmacology, Vol. 7, Iss. 1, 2012-02 ,pp. : 66-72

Bentham Science Publishers

Access to resources Recommend Favorite

Gut Inflammation: Current Update on Pathophysiology, Molecular Mechanism and Pharmacological Treatment Modalities

Current Pharmaceutical Design, Vol. 20, Iss. 7, 2014-02 ,pp. : 1063-1081

Bentham Science Publishers

Access to resources Recommend Favorite